Use of ARTRA MSM FORTE in patients with knee osteoarthritis: Results of a randomized open-label comparative study of the efficacy and tolerability of the drug
- Authors: Alekseeva LI1, Sharapova EP1, Kashevarova NG1, Taskina EA1, Anikin SG1, Korotkova TA1, Pyanykh SE2
-
Affiliations:
- «НИИ ревматологии им. В.А. Насоновой»
- Представительство Корпорации «Юнифарм, Инк.»
- Issue: Vol 87, No 12 (2015)
- Pages: 49-54
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31873
- ID: 31873
Cite item
Full Text
Abstract
Keywords
About the authors
L I Alekseeva
«НИИ ревматологии им. В.А. Насоновой»Москва, Россия
E P Sharapova
«НИИ ревматологии им. В.А. Насоновой»Москва, Россия
N G Kashevarova
«НИИ ревматологии им. В.А. Насоновой»Москва, Россия
E A Taskina
«НИИ ревматологии им. В.А. Насоновой»Москва, Россия
S G Anikin
«НИИ ревматологии им. В.А. Насоновой»Москва, Россия
T A Korotkova
«НИИ ревматологии им. В.А. Насоновой»Москва, Россия
S E Pyanykh
Представительство Корпорации «Юнифарм, Инк.»Москва, Россия
References
- McAlindon T, Bannuru R, Sullivan M, Arden N, Berenbaum F, Bierma-Zeinstra S, Hawker G, Henrotin Y, Hunter D, Kawaguch, H, Kwoh K, Lohmander S, Rannou F, Roos E, Underwood M. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-388. doi: 10.1016/j.joca.2015.02.014.
- Henrotin Y, Marty M, Mobasheri A. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas 2014;78:184-187. doi: 10.1016/j.maturitas.2014.07.018.
- Bruyère O, Cooper C, Pelletier J, Branco J, Brandi LM, Guillemin F, Hochberg MC, Kanis JA, Kvien TK, Martel-Pelletier J, Rizzoli R, Silverman S, Reginster J. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism, 2014:2-11. doi: 10.1016/j.semarthrit.2014.05.014.
- Hochberg M, Martel-Pelletier J, Monfort J, Moller I, Castillo JR, Arden N, Berenbaum F, Conaghan P, Pap T, Richette P, Sawitzke A, du Souich P, Pelletier JP. The Multicentric Osteoarthritis interVEntion Study with Sysadoa (MOVES). MOVES Steering Committee. Osteoarthritis and Cartilage. 2014;22:S7-S56. doi: 10.1136/annrheumdis-2014-eular.4950.
- Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S, Jan S, March L, Edmonds J, Norton R, Woodward M, Day R. Glucosamine and chondroitin for knee placebo- controlled clinical trial evaluating osteoarthritis: a double-blind randomized single and combination regimens. Ann Rheum Dis. 2014;0:1-8. doi: 10.1136/annrheumdis-2013-20395.
- Martel-Pelletier J, RoubilleC, AbramF, Hochberg MC et al. Data from the osteoarthritis initiative progression cohort Published Online First 13 December 2013. doi: 10.1107/s1600536806054936.
- Alekseeva L, Chichasova N, Mendel O. Rational choice of basic therapy in osteoarthritis. The results of a multicenter, randomized, open study ARTRA in Russia. RMJ 2005;24(248):1637-1640.
- Kocsis JJ, Harkaway S, Snyder R. Biological effects of the metabolites of dimethyl sulfoxide. Ann New York Academy of Sciences. 1975;243:104-109. doi: 10.1111/j.1749-6632.1975.tb25349.x.
- Hucker HB, Miller JK, Hochberg A, Brobyn RD, Riordan FH, Calesnick B. Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man. J Pharmacol Exper Ther. 1967;155:309-317.
- Engelke UF, Tangerman A, Willemsen MA, Moskau D, Loss S, Mudd SH, Wevers RA. Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by onedimensional (1) H and two-dimensional (1)H-(13)C NMR. J Radiol Nucl Med. 2005; 18:331-336. doi: 10.1002/nbm.966.
- Ebisuzaki K. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res. 2003;23:453-458.
- Alam SS, Layman DL. Dimethyl sulfoxide inhibition of prostacyclin production in cultured aortic endothelial cells. Ann New York Academy Scie. 1983;411:318-320. doi: 10.1111/j.1749-6632.1983.tb47314.x.
- Beilke MA, Collins-Lech C, Sohnle PG. Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J Lab Clin Med. 1987;110:91-96.
- Morton J, Moore R. Lupus nephritis and deaths are diminished in B/W mice drinking 3% water solutions of dimethyl sulfoxide (DMSO) or dimethyl sulfone (DMSO2). J Leukocyte Biol. 1986; 40:322.
- Hasegawa T. Suppressive effect of methylsulfonylmethane (MSM) on type II collagen-induced arthritis in DBA/1J mice. Japanese Pharmacol Ther. 2004;32:421-427.
- Usha P, Naidu M. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Investigat. 2004;24:353-363. doi: 10.2165/00044011-200424060-00005.
- Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. OsteoArthritis and Cartilage. 2006;14:286-294. doi: 10.1016/j.joca.2005.10.003.
- Pagonis TA, Givissis PK, Kritis AC, Christodoulou AC. The Effect of Methylsulfonylmethane on Osteoarthritic Large Joints and Mobility. Int J Orthopaed. 2014;1(1):19-24. doi:http://dx.doi.org/10.1016/j.injury.2011.03.018.
- Sudha Vidyasagar, Prabhu Mukhyaprana, U. Shashikiran, Adiga Sachidananda, Sharath Rao, K. Laxminarayana Bairy, Shalini Adiga and B. Jayaprakash. Efficacy and Tolerability of Glucosamine Chondroitin Sulphate — Methyl Sulfonyl Methane (MSM) in Osteoarthritis of Knee in Indian Patients. Int J Pharm Technol. 2004;3:61-65.